Statistics for Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience
Total visits
| views | |
|---|---|
| Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience | 24 |
Total visits per month
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
File Visits
| views | |
|---|---|
| 16563.pdf | 1 |
Top country views
| views | |
|---|---|
| Portugal | 20 |
| Brazil | 2 |
| United States | 2 |